Efficacy, safety, and patient-reported outcomes across young to older age groups of patients with HR+/HER2- advanced breast cancer treated with ribociclib plus endocrine therapy in the randomized MONALEESA-2, -3, and -7 trials.
Saved in:
| Title: | Efficacy, safety, and patient-reported outcomes across young to older age groups of patients with HR+/HER2- advanced breast cancer treated with ribociclib plus endocrine therapy in the randomized MONALEESA-2, -3, and -7 trials. |
|---|---|
| Authors: | Hart LL; Florida Cancer Specialists, Sarah Cannon Research Institute, Fort Myers, FL, USA; Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: llhart@wakehealth.edu., Im SA; Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea., Tolaney SM; Dana-Farber Cancer Institute, Boston, MA, USA., Campone M; Institut de Cancérologie de l'Ouest/René Gauducheau Centre de Recherche en Cancérologie, St. Herblain, France., Pluard T; Saint Luke's Cancer Institute, Kansas City, MO, USA., Sousa B; Breast Unit, Champalimaud Clinical and Research Center/Champalimaud Foundation, Lisbon, Portugal., Freyer G; Oncology Department, Hôpital Lyon Sud, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL) and Université de Lyon, France., Decker T; Gemeinschaftspraxis für Hämatologie und Onkologie Ravensburg, Germany., Kalinsky K; Winship Cancer Institute at Emory University, Atlanta, GA, USA., Sopher G; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Gao M; Novartis Pharma AG, Basel, Switzerland., Hu H; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Kuemmel S; Department of Gynecology with Breast Unit, Charité Hospital Berlin, Germany; Interdisciplinary Breast Unit, Kliniken Essen Mitte, Essen, Germany. |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Feb 25; Vol. 217, pp. 115225. Date of Electronic Publication: 2025 Jan 08. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
